Valuation: CVRx, Inc.

Market Cap 79.13M 69.15M 64.99M 59.31M 111M 7.56B 111M 780M 301M 3.86B 297M 291M 12.45B P/E 2026 *
-1.43x
P/E 2027 * -1.51x
Enterprise Value 89.63M 78.33M 73.62M 67.18M 126M 8.57B 126M 884M 341M 4.38B 337M 329M 14.11B EV / Sales 2026 *
1.52x
EV / Sales 2027 * 1.84x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day-2.69%
1 week-3.67%
Current month-2.36%
1 month+1.76%
3 months-40.53%
6 months-66.74%
Current year-59.30%
1 week 2.86
Extreme 2.86
3.1
1 month 2.7
Extreme 2.7
3.42
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 2024-02-11
Director of Finance/CFO 43 2020-09-30
Chief Operating Officer 57 2025-08-10
Director TitleAgeSince
Director/Board Member 61 2008-09-30
Director/Board Member 57 2020-06-30
Director/Board Member 52 2020-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
8/13/26 Buy

Chief Operating Officer

26,223 0.0988%
8/12/26 Sell

Chief Operating Officer

-1,309 0.0049%
6/1/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-2.69%-3.67%-61.62%-80.15% 79.13M
+0.19%+0.30%+25.91%+29.03% 12.56B
+1.95%+3.15%+16.46%+23.68% 6.67B
+0.38%-3.68% - - 5.94B
-0.21%+0.74%+28.03%+21.61% 5.52B
-0.03%-1.96%-19.13%+39.04% 5.06B
+0.76%+4.20%-31.52%-21.85% 3.92B
+0.85%+3.22%+27.35%-3.92% 1.92B
+0.87%-4.92%-19.78%+170.40% 1.66B
-1.95%+0.60%+48.74%-15.31% 1.57B
Average +0.01%-0.04%+1.61%+18.06% 4.49B
Weighted average by Cap. +0.43%+0.08%+11.83%+25.62%

Financials

2026 *2027 *
Net sales 58.85M 51.43M 48.34M 44.11M 82.79M 5.63B 82.81M 580M 224M 2.87B 221M 216M 9.26B 66.18M 57.83M 54.36M 49.6M 93.1M 6.33B 93.12M 652M 252M 3.23B 249M 243M 10.42B
Net income -53.45M -46.71M -43.9M -40.06M -75.19M -5.11B -75.21M -527M -203M -2.61B -201M -196M -8.41B -52.14M -45.56M -42.82M -39.08M -73.34M -4.98B -73.35M -514M -198M -2.55B -196M -191M -8.21B
Net Debt 10.5M 9.18M 8.63M 7.87M 14.78M 1B 14.78M 104M 39.95M 513M 39.44M 38.58M 1.65B 42.94M 37.52M 35.27M 32.18M 60.4M 4.1B 60.41M 423M 163M 2.1B 161M 158M 6.76B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
26-09-22 US$2.890 -2.69% 666,180
26-09-21 US$2.970 -2.30% 289,629
26-09-18 US$3.040 +1.33% 810,573
26-09-17 US$3.000 -0.66% 301,154
26-09-16 US$3.020 +0.67% 415,886
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.890USD
Average target price
4.583USD
Spread / Average Target
+58.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!